TNF and inflammatory bowel disease: Tracking the immune status in IBD based on miRNA signatures determined from liquid or tissue biopsies, may be powerful for designing individualized therapies that could be, e.g., combinations of conventional drugs and biologically active drugs, like anti-TNF.